Labetalol HCl in all strengths, all doses, and all packaging.
Published February 28, 2018 · Recall initiated: December 27, 2017
Summary
FDA records drug Class II recall D-0447-2018, published February 28, 2018 and initiated December 27, 2017. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: Unknown; Lot: All lots remaining within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmedium Services, LLC
- Distributor
- U.S.A. Nationwide
- Lot
- All lots remaining within expiry.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 254.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 508.00January 1, 2020
- FDAFentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%,December 26, 2018
- FDAPotassium Chloride in 5% Dextrose in all strengths, all doses, and all packaging.February 28, 2018
- FDAMethadone HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.February 28, 2018
Questions about this recall
Was Labetalol HCl in all strengths, all doses, and all packaging. recalled?
Yes. FDA published recall D-0447-2018 on February 28, 2018. Reported hazard: Lack of sterility assurance.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release